TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29556144

Group type: EXPERIMENTAL
Intervention: Scoring system derived from backward stepwise logistic regression model
Number of subjects: 976

Group type: EXPERIMENTAL
Intervention: Scoring system with total score >9.5
Number of subjects: 976

Group type: EXPERIMENTAL
Intervention: Independent predictors of CSX
Number of subjects: 976
Study: 27737480

Group type: EXPERIMENTAL
Intervention: Home management
Number of subjects: 239

Group type: COMPARATOR
Intervention: Hospital management
Number of subjects: 239
Study: 24998039

Group type: EXPERIMENTAL
Intervention: Soft-layered spineboard
Number of subjects: 30

Group type: COMPARATOR
Intervention: Rigid spineboard
Number of subjects: 30
Study: 23218961

Group type: EXPERIMENTAL
Intervention: Differential suction electrode (DSE) probe
Number of subjects: 20

Group type: COMPARATOR
Intervention: Femiscan™ probe
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both probes
Number of subjects: 20
Study: 20216532

Group type: EXPERIMENTAL
Intervention: 19-gauge needle
Number of subjects: 117

Group type: COMPARATOR
Intervention: 22-gauge needle
Number of subjects: 117
Study: 18398080

Group type: EXPERIMENTAL
Intervention: Aggressive treatment (LDL-C target of 70 mg/dL or lower, SBP target of 115 mm Hg or lower)
Number of subjects: 499

Group type: COMPARATOR
Intervention: Standard treatment (LDL-C target of 100 mg/dL or lower, SBP target of 130 mm Hg or lower)
Number of subjects: 499

Group type: EXPERIMENTAL
Intervention: Aggressive treatment
Number of subjects: 499

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 499
Study: 15343465

Group type: EXPERIMENTAL
Intervention: Closed-tube thoracostomy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Open thoracotomy
Number of subjects: 30
Study: 11395836

Group type: EXPERIMENTAL
Intervention: Sea‐Bands with acupressure on both wrists
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Sea‐Bands with acupressure on one wrist
Number of subjects: 157

Group type: COMPARATOR
Intervention: Wristband without acupressure on both wrists
Number of subjects: 157

Group type: COMPARATOR
Intervention: Wristband without acupressure on one wrist
Number of subjects: 157

Group type: COMPARATOR
Intervention: No wristband
Number of subjects: 157
Study: 9664269

Group type: EXPERIMENTAL
Intervention: Manual lymph drainage (MLD) for 45 min/day for 2 weeks
Number of subjects: 28

Group type: COMPARATOR
Intervention: Sequential pneumatic compression (SPC) with a pressure of 40‐60 mmHg for 2 hours/day for 2 weeks
Number of subjects: 28
Study: 2905064

Group type: EXPERIMENTAL
Intervention: Suspension therapy (abrupt discontinuation of neuroleptics)
Number of subjects: 159
Study: 30508408

Group type: EXPERIMENTAL
Intervention: Anodal tsDCS (2.0 mA, 20 minutes, five days)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Sham tsDCS
Number of subjects: 11
Study: 30796110

Group type: EXPERIMENTAL
Intervention: Light therapy (10,000 lux)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo light therapy
Number of subjects: 83
Study: 28280882

Group type: EXPERIMENTAL
Intervention: Alcohol (0.8 g/kg)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 155
Study: 26125807

Group type: EXPERIMENTAL
Intervention: Enteral nutrition starting 1 week before surgery
Number of subjects: 200

Group type: COMPARATOR
Intervention: Enteral nutrition starting early after surgery
Number of subjects: 200
Study: 23280459

Group type: EXPERIMENTAL
Intervention: Person-centered planning and collaborative documentation
Number of subjects: 367

Group type: COMPARATOR
Intervention: Usual treatment
Number of subjects: 367
Study: 21980992

Group type: EXPERIMENTAL
Intervention: Serotonin-depleting LNAA mixture
Number of subjects: 15

Group type: COMPARATOR
Intervention: Protein control (PC) LNAA mixture
Number of subjects: 15
Study: 18298873

Group type: EXPERIMENTAL
Intervention: Propofol-remifentanil
Number of subjects: 42

Group type: COMPARATOR
Intervention: Sevoflurane-N2O
Number of subjects: 42
Study: 16795979

Group type: EXPERIMENTAL
Intervention: D2 dissection (N = 128)
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: D4 dissection (N = 128)
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: D4 dissection plus pancreatosplenectomy
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: D2 dissection plus pancreatosplenectomy
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Both D2 and D4 groups
Number of subjects: 256
Study: 12599240

Group type: EXPERIMENTAL
Intervention: Darbepoetin alpha (4.5 microg/kg per week for 4 weeks, then 2.25 microg/kg per week for 8 weeks)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Darbepoetin alpha (4.5 microg/kg per week for 4 weeks, then 3.0 microg/kg every 2 weeks)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Darbepoetin alpha (4.5 microg/kg per week until hemoglobin concentration >or= 12 g/dL, then 1.5 microg/kg per week)
Number of subjects: 127

Group type: COMPARATOR
Intervention: rHuEPO (40,000 U with escalations to 60,000 U for nonresponders)
Number of subjects: 127
Study: 10905680

Group type: EXPERIMENTAL
Intervention: Internal fixation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Hemiarthroplasty
Number of subjects: 60

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 60
Study: 9354343

Group type: EXPERIMENTAL
Intervention: Zidovudine
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study: 8473547

Group type: EXPERIMENTAL
Intervention: Cimetidine 800 mg once daily
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Ranitidine 300 mg once daily
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control
Number of subjects: 9
Study: 3006368

Group type: EXPERIMENTAL
Intervention: Mackerel diet
Number of subjects: 14

Group type: COMPARATOR
Intervention: Herring diet
Number of subjects: 14
Study: 31072970

Group type: EXPERIMENTAL
Intervention: Conscious Sedation
Number of subjects: 92

Group type: COMPARATOR
Intervention: General Anesthesia
Number of subjects: 92

Group type: COMPARATOR
Intervention: Medical Management
Number of subjects: 92
Study: 30139771

Group type: EXPERIMENTAL
Intervention: Supplemental oxygen (40% inspired)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sham (air)
Number of subjects: 36
Study: 27193497

Group type: EXPERIMENTAL
Intervention: Ubiquinol (200 mg/day)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 24672935

Group type: EXPERIMENTAL
Intervention: Blood activating water relieving method (BAWRM)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Routine Western medical treatment (Control)
Number of subjects: 64
Study: 23037460

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 600 mg intravenously before CECT imaging
Number of subjects: 209

Group type: COMPARATOR
Intervention: Control group (standard hydration strategy)
Number of subjects: 209
Study: 20484704

Group type: EXPERIMENTAL
Intervention: Experienced listeners (5 otolaryngologists and 5 speech-language pathologists)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Inexperienced listeners (medical professionals with no formal training in voice disorders)
Number of subjects: 21
Study: 19091932

Group type: EXPERIMENTAL
Intervention: 10-week online self-management education and peer support program
Number of subjects: 30
Study: 14766488

Group type: EXPERIMENTAL
Intervention: Part-whole practice (100 repetitions of the 8-element sequence on Day 1 and 100 repetitions of the 16-element sequence on Day 2)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Whole-practice (100 repetitions of the 16-element sequence on both days)
Number of subjects: 18
Study: 12206794

Group type: EXPERIMENTAL
Intervention: Intramuscular administration of dystrophin cDNA
Number of subjects: 9
Study: 9667605

Group type: EXPERIMENTAL
Intervention: Secondary MAD deficiency
Number of subjects: 0

Group type: COMPARATOR
Intervention: Primary MAD deficiency
Number of subjects: 0

Group type: COMPARATOR
Intervention: General population
Number of subjects: 0
Study: 7907098

Group type: EXPERIMENTAL
Intervention: Antipsychotic withdrawal (n = 64)
Number of subjects: 271

Group type: COMPARATOR
Intervention: Continued use of antipsychotics (n = 207)
Number of subjects: 271
Study: 2510253

Group type: EXPERIMENTAL
Intervention: Rioprostil (300 micrograms)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Rioprostil (600 micrograms)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 30857258

Group type: EXPERIMENTAL
Intervention: Shellfish gatherers with more than 26 years of work experience
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Shellfish gatherers more exposed to work sitting with trunk flexion
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Shellfish gatherers performing manual handling and muscle force with the arms
Number of subjects: 209
Study: 28235817

Group type: EXPERIMENTAL
Intervention: Involvement of posterior limb of internal capsule
Number of subjects: 2066

Group type: EXPERIMENTAL
Intervention: Involvement of thalamus
Number of subjects: 2066

Group type: EXPERIMENTAL
Intervention: Involvement of infratentorial sites
Number of subjects: 2066

Group type: EXPERIMENTAL
Intervention: ICH encompassing thalamus and posterior limb of internal capsule
Number of subjects: 2066
Study: 25896283

Group type: EXPERIMENTAL
Intervention: Incremental exercise lifting (5 kg load increased by 2 kg every 2 min until fatigue)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Incremental exercise lifting
Number of subjects: 20
Study: 24436950

Group type: EXPERIMENTAL
Intervention: Periodontal nonsurgical treatment including oral hygiene instruction and scaling and root planing
Number of subjects: 75

Group type: COMPARATOR
Intervention: Oral hygiene instruction only
Number of subjects: 75
Study: 21688877

Group type: EXPERIMENTAL
Intervention: Motivational Enhancement Therapy (MET)
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Educational Feedback Control (EFC)
Number of subjects: 310

Group type: COMPARATOR
Intervention: Delayed Feedback Control (DFC)
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: All conditions (MET, EFC, DFC)
Number of subjects: 310
Study: 18279406

Group type: EXPERIMENTAL
Intervention: Mechanical ICE monitoring
Number of subjects: 82

Group type: COMPARATOR
Intervention: Electronic ICE monitoring
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 82
Study: 17062645

Group type: EXPERIMENTAL
Intervention: McKenzie Approach (McK)
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Solution-Finding Approach (SFA)
Number of subjects: 315

Group type: COMPARATOR
Intervention: Both interventions
Number of subjects: 315
Study: 12894866

Group type: EXPERIMENTAL
Intervention: Video reinforcement (moving images generated by a digital video disc player/monitor)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional reinforcement (animated mechanical toy)
Number of subjects: 40
Study: 16737346

Group type: EXPERIMENTAL
Intervention: Tailored intervention
Number of subjects: 501

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 501
Study: 10580352

Group type: EXPERIMENTAL
Intervention: sulodexide (600 lipoprotein lipase releasing units [LRU] by im route per day for 30 consecutive days, followed by 500 LRU by oral route per day for a further 30 days)
Number of subjects: 94

Group type: COMPARATOR
Intervention: standard treatment (cleansing with physiological solution and elastic compression with short‐extensibility, removable bandages)
Number of subjects: 94
Study: 9772600

Group type: EXPERIMENTAL
Intervention: Xinjikang capsule (XJK)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Metoprolo (Control)
Number of subjects: 94
Study: 1927852

Group type: EXPERIMENTAL
Intervention: Low-dose amiodarone (400 mg/day for 4 weeks, then 200 mg/day)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Low-dose amiodarone
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Low-dose amiodarone (with >75% reduction in ectopy)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo (with <=75% ectopic suppression)
Number of subjects: 101
Study: 6749270

Group type: EXPERIMENTAL
Intervention: Cefamandole
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82

Group type: COMPARATOR
Intervention: No antibiotics
Number of subjects: 82
Study: 31455688

Group type: EXPERIMENTAL
Intervention: 0 g fat
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 20 g fat
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 40 g fat
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 60 g fat
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Saturated, monounsaturated, or polyunsaturated fat
Number of subjects: 0
Study: 26084869

Group type: EXPERIMENTAL
Intervention: Intensive glycemic management with continuous insulin infusion (target glucose 4.4‐6.1 mmol/l)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Conventional glycemic management with intermittent bolus insulin (target glucose <11.1 mmol/l)
Number of subjects: 212
Study: 24631949

Group type: EXPERIMENTAL
Intervention: NEPA (NETU 300 mg + PALO 0.50 mg) with oral dexamethasone (DEX)
Number of subjects: 413

Group type: COMPARATOR
Intervention: Aprepitant (APR) regimen + PALO + DEX
Number of subjects: 413

Group type: EXPERIMENTAL
Intervention: NEPA
Number of subjects: 413
Study: 22270487

Group type: EXPERIMENTAL
Intervention: Viewing nature scenes
Number of subjects: 29

Group type: COMPARATOR
Intervention: Built scenes
Number of subjects: 29
Study: 19604523

Group type: EXPERIMENTAL
Intervention: L-carnitine 2 g/d and simvastatin 20 mg
Number of subjects: 80

Group type: COMPARATOR
Intervention: simvastatin monotherapy 20 mg
Number of subjects: 80
Study: 16824762

Group type: EXPERIMENTAL
Intervention: Gait training with functional neuromuscular stimulation (FNS) using intramuscular (IM) electrodes
Number of subjects: 37

Group type: COMPARATOR
Intervention: Gait training without FNS (No-FNS)
Number of subjects: 37
Study: 15047004

Group type: EXPERIMENTAL
Intervention: Cortical BMD (BMD(C)) in hemodialysis patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cortical bone area, cortical thickness, moment of inertia, polar moment of inertia in hemodialysis patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Duration of hemodialysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Serum alkaline phosphatase and intact parathyroid hormone levels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prolonged hemodialysis and secondary hyperparathyroidism
Number of subjects: 0
Study: 12202469

Group type: EXPERIMENTAL
Intervention: Calcitonin
Number of subjects: 2260
Study: 9679526

Group type: EXPERIMENTAL
Intervention: Sargramostim (yeast-derived RhuGM-CSF)
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Filgrastim (bacteria-derived RhuG-CSF)
Number of subjects: 181
Study: 8024910

Group type: EXPERIMENTAL
Intervention: ACE inhibitor (ramipril)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Beta 1 blocker (metoprolol)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3
Study: 2688940

Group type: EXPERIMENTAL
Intervention: Qigong therapy with regularly antihypertensive drug taking (n = 50)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group with regularly antihypertensive drug taking only (n = 50)
Number of subjects: 100
Study: 30386978

Group type: EXPERIMENTAL
Intervention: CARE Express (2-hour training)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: CARE (1-day training)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 147
Study: 31229087

Group type: EXPERIMENTAL
Intervention: Carotenoid-rich 'matrix-free' formulation (0.8 mg sapotexanthin, 1.2-1.5 mg cryptocapsin)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Fresh Mamey sapote fruit (0.8 mg sapotexanthin, 1.2-1.5 mg cryptocapsin)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Both test meals (fresh fruit and matrix-free formulation)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Carotenoid-rich 'matrix-free' formulation
Number of subjects: 13
Study: 28042685

Group type: EXPERIMENTAL
Intervention: Lumbopelvic stabilization training (LPST)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Passive automated cycling intervention
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 25
Study: 25595177

Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept injection
Number of subjects: 12
Study: 23286463

Group type: EXPERIMENTAL
Intervention: Computerized treatment for insomnia
Number of subjects: 228
Study: 21569488

Group type: EXPERIMENTAL
Intervention: Group Cognitive Behavioural Therapy (CBT) for 12 weeks
Number of subjects: 73

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 73
Study: 19910942

Group type: EXPERIMENTAL
Intervention: Walnut breakfast shakes
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo breakfast shakes
Number of subjects: 20
Study: 18023662

Group type: EXPERIMENTAL
Intervention: Intraoperative nasopharyngeal temperature of 34 degrees C (hypothermic)
Number of subjects: 267

Group type: COMPARATOR
Intervention: Intraoperative nasopharyngeal temperature of 37 degrees C (normothermic)
Number of subjects: 267
Study: 16286127

Group type: EXPERIMENTAL
Intervention: Subinguinal approach
Number of subjects: 99

Group type: COMPARATOR
Intervention: Inguinal approach
Number of subjects: 99
Study: 12032583

Group type: EXPERIMENTAL
Intervention: High-dose intravenous immunoglobulin G (IVIg)
Number of subjects: 0
Study: 10190913

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (iNO) therapy (10 ppm)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Mechanical ventilation alone
Number of subjects: 108
Study: 7753573

Group type: EXPERIMENTAL
Intervention: Electrical stimulation cycle ergometry (ESCE) for 30 min
Number of subjects: 6

Group type: COMPARATOR
Intervention: Continuous passive motion (CPM) for 30 min
Number of subjects: 6
Study: 2153881

Group type: EXPERIMENTAL
Intervention: Hines VA Hospital‐based Home Care (HBHC) Program
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Caregivers of HBHC patients
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Treatment group
Number of subjects: 233
Study: 7353752

Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo (after cross-over)
Number of subjects: 6
Study: 31792856

Group type: EXPERIMENTAL
Intervention: 15‐keto fluprostenol (35 μg/ml)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31016812

Group type: EXPERIMENTAL
Intervention: Explicitly described right-skewed survival curve
Number of subjects: 238

Group type: COMPARATOR
Intervention: Standard communication without right-skewed survival curve
Number of subjects: 238
Study: 28275128

Group type: COMPARATOR
Intervention: LNS-LNS
Number of subjects: 3379

Group type: COMPARATOR
Intervention: IFA-LNS
Number of subjects: 3379

Group type: COMPARATOR
Intervention: IFA-MNP
Number of subjects: 3379

Group type: COMPARATOR
Intervention: IFA-Control
Number of subjects: 3379
Study: 25519996

Group type: EXPERIMENTAL
Intervention: Cytoreductive radical prostatectomy (group A)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Androgen deprivation therapy (ADT) alone (group B)
Number of subjects: 23
Study: 24079282

Group type: EXPERIMENTAL
Intervention: Fenofibrate (160 mg/d)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Extended-release niacin (0.5 g/d for 3 weeks, then 1 g/d)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Fenofibrate and ER niacin
Number of subjects: 66
Study: 21334569

Group type: EXPERIMENTAL
Intervention: Combination therapy (alternative SSRI plus CBT)
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Combination therapy (venlafaxine plus CBT)
Number of subjects: 334

Group type: COMPARATOR
Intervention: Medication mono-therapy
Number of subjects: 334
Study: 19243423

Group type: EXPERIMENTAL
Intervention: Levetiracetam (40 mg/kg/day for age 1 to <6 months; 50 mg/kg/day for age >or=6 months to <4 years)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study: 17579892

Group type: EXPERIMENTAL
Intervention: Combination of flaxseed (FS) with soy protein or genistein (GEN) with enterodiol (END) and enterolactone (ENL)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Soy protein or genistein (GEN) alone
Number of subjects: 0
Study: 14758212

Group type: EXPERIMENTAL
Intervention: Fibrin glue-anchored Integra with postoperative negative-pressure therapy
Number of subjects: 12

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 12
Study: 11282808

Group type: EXPERIMENTAL
Intervention: Citalopram (20-60 mg)
Number of subjects: 427

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 427
Study: 9153607

Group type: EXPERIMENTAL
Intervention: 6 mg subcutaneous sumatriptan
Number of subjects: 803

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 803
Study: 7696887

Group type: EXPERIMENTAL
Intervention: Nandrolone decanoate (50 mg every 3 weeks)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: 1-alpha-hydroxy-calciferol (1 microgram daily)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo (inactive drug)
Number of subjects: 88
Study: 3229387

Group type: EXPERIMENTAL
Intervention: Large-volume group (LVG) injected with up to 30 ml per session
Number of subjects: 39

Group type: COMPARATOR
Intervention: Small-volume group (SVG) injected with up to 15 ml per session
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Large-volume group (LVG)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Small-volume group (SVG)
Number of subjects: 39
Study: 28378199

Group type: EXPERIMENTAL
Intervention: Standard dissemination (mailed materials)
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Enhanced dissemination (mailed materials plus follow-up call)
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Charla (face-to-face group discussion)
Number of subjects: 254
Study: 27515872

Group type: EXPERIMENTAL
Intervention: Withania somnifera extract (120 mg/day), n = 15
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo, n = 15
Number of subjects: 30
Study: 24974901

Group type: EXPERIMENTAL
Intervention: 20 ml levobupivacaine 0.5%
Number of subjects: 51

Group type: COMPARATOR
Intervention: 20 ml saline 0.9% (control group)
Number of subjects: 51
Study: 22490197

Group type: EXPERIMENTAL
Intervention: Compound whole grain and health education
Number of subjects: 418

Group type: COMPARATOR
Intervention: Health education
Number of subjects: 418
Study: 20537611

Group type: EXPERIMENTAL
Intervention: Interferon-alpha (n = 19)
Number of subjects: 31

Group type: COMPARATOR
Intervention: No treatment (n = 12)
Number of subjects: 31
Study: 18946563

Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Ondansetron 4 mg
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75